EUVIMEDEUVIMED entdecken
Open Access

Recovery of Parosmia Preferentially Influences Longitudinal Improvement of Quality of Life in C19OD

Tiana M Saak iD, Jeremy P Tervo iD, Brandon J Vilarello, Patricia T Jacobson, Francesco F Caruana, Liam W Gallagher, David A Gudis iD, Davangere P Devanand, Jonathan B Overdevest iD

International Forum of Allergy & Rhinology · 2026

DOI: 10.1002/alr.70149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2026. Verfasst von Tiana M Saak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA. Hauptthemen laut MEDLINE: Quality of Life, Olfaction Disorders, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCD NIH HHS, NIH HHS, National Institute on Deafness and Other Communication Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Persistent COVID‐associated olfactory dysfunction (C19OD) negatively impacts quality of life (QoL). This prospective longitudinal cohort study sought to determine which aspects of chemosensory recovery may preferentially influence QoL improvement in this population.

Methods

Individuals with C19OD ( N = 100) completed chemosensory and QoL assessment with Sniffin’ Sticks, Taste Assessment, Questionnaire of Olfactory Disorders‐Negative Statements (QOD‐NS), and QOD‐PAR at baseline and 1 year. Multivariable analyses assessed baseline and longitudinal associations between chemosensory dysfunction and QOD‐NS.

Results

QoL associated with TDI (Coef.; [CI]; p ‐value: −0.32; [−0.62, −0.032]; 0.030), threshold (−0.82; [−1.5, −0.14]; 0.019), QOD‐Par (−1.0; [−0.20, −1.9]; 0.016), and self‐reported gustatory dysfunction (GD) (−7.4; [−14, −0.46]; 0.037) at baseline assessment, though quantitative GD did not associate with QoL. Longitudinally, improvements in discrimination (−1.2; [−2.3, −0.18]; 0.023) and QOD‐Par (−2.5; [−0.99, −4.1]; 0.002) scores were associated with improved QoL. Individuals with improved parosmia symptoms experienced a 12.86 (12.99, 0.040) QOD‐NS point improvement from baseline compared to 5.91 (7.98, < 0.001) for those with persistent parosmia.

Conclusions

Independent of mental health, chemosensory function independently drives QoL in C19OD. Parosmia, low odor threshold, and patient‐reported GD are all associated with poorer QoL at baseline. Longitudinally, the ability to differentiate among odors is an important correlate of improvement of smell‐related QoL in C19OD patients, while parosmia is the strongest driver of longitudinal recovery of smell‐related QoL in C19OD. Trending domain‐specific olfactory performance in C19OD may allow for improved patient counseling and QoL prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeOlfaction DisordersCOVID-19HumansFemaleMiddle AgedMaleLongitudinal StudiesAdultProspective StudiesSmellAgedSurveys and QuestionnairesSARS-CoV-2

Stichwörter der Autor:innen

COVID‐19chemosensationquality of lifesmell

Autor:innen und Institutionen

  • Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.
  • Department of Otolaryngology-Head and Neck Surgery, New York-Presbyterian/Columbia University Irving Medical Center, New York, New York, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Tiana M Saak, Jeremy P Tervo, David A Gudis, Jonathan B Overdevest

Förderung

  • NIDCD NIH HHS
  • NIH HHS
  • National Institute on Deafness and Other Communication Disorders
  • National Institutes of Health

Zitieren

APA

Saak, T. M., Tervo, J. P., Vilarello, B. J., Jacobson, P. T., Caruana, F. F., Gallagher, L. W., Gudis, D. A., Devanand, D. P., & Overdevest, J. B. (2026). Recovery of Parosmia Preferentially Influences Longitudinal Improvement of Quality of Life in C19OD. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.70149

Vancouver

Saak TM, Tervo JP, Vilarello BJ, Jacobson PT, Caruana FF, Gallagher LW, et al. Recovery of Parosmia Preferentially Influences Longitudinal Improvement of Quality of Life in C19OD. International Forum of Allergy & Rhinology. 2026. doi:10.1002/alr.70149

BibTeX
@article{Saak2026,
  author = {Saak, Tiana M and Tervo, Jeremy P and Vilarello, Brandon J and Jacobson, Patricia T and Caruana, Francesco F and Gallagher, Liam W and Gudis, David A and Devanand, Davangere P and Overdevest, Jonathan B},
  title = {Recovery of Parosmia Preferentially Influences Longitudinal Improvement of Quality of Life in C19OD},
  journal = {International Forum of Allergy & Rhinology},
  year = {2026},
  doi = {10.1002/alr.70149}
}
Kostenlos starten →